Health Sciences Acquisitions 2 restates financial statements due to equity classification error

Orchestra BioMed Holdings, Inc.

Audit committee concludes all ordinary shares should be classified as temporary equity, not permanent.
Restatement covers six prior filings from August 2020 through September 2021, including IPO balance sheet.
No impact on cash position or trust account; earnings per share presentation also revised.
Material weakness in internal control over financial reporting identified; disclosure controls ineffective.
Company plans to file amended 10-K, 10-Q, and 8-K to correct the affected periods.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.